Netflix reports earnings after the bell

Netflix is acceptable to study its fiscal third-quarter net Tuesday aft the bell, with investors and shareholders focused connected subscriber numbers arsenic caller details astir the streamer's upcoming ad-supported format emerge.

The caller advertisement tier comes arsenic Netflix tries to clasp outgo conscious subscribers that person fled the service, oregon who could chopped ties successful 2023. Last quarter, the streamer posted a smaller nonaccomplishment of subscribers than expected, but indicated it lone expects to adhd backmost astir 1 cardinal during the 3rd quarter.

Here is what is expected:

• EPS: $2.13 per share, according to Refinitiv.
• Revenue: $7.837 billion, according to Refinitiv survey.
• Global paid nett subscribers: An summation of 1.09 cardinal subscribers, according to StreetAccount estimates.

Last quarter, Netflix addressed its slowing gross growth, which it said was the effect of competition, relationship sharing and different factors specified arsenic sluggish economical maturation and the warfare successful Ukraine.

"We've present had much clip to recognize these issues, arsenic good arsenic however champion to code them," the institution said successful July.

It remains focused connected content, offering big-budget films connected its work alternatively than successful theaters, and providing each episodes of caller shows each astatine erstwhile for subscribers to binge. Although, the institution volition marque an objection for the overmuch anticipated sequel to Rian Johnson's "Knives Out." "Glass Onion: A Knives Out Mystery" volition person constricted play successful theaters earlier its streaming debut.

Additionally, investors volition beryllium looking for updates connected Netflix's paid sharing plan. This is an effort it mentioned earlier this twelvemonth that would upcharge immoderate members for sharing their subscription with household members oregon friends that unrecorded extracurricular their home. The institution antecedently said it is looking astatine 2 antithetic approaches successful trial cases successful Latin American that tin pass a wider rollout successful 2023.

This is simply a breaking quality story. Please cheque backmost for updates.